Company OUTLOOK THERAPEUTICS, INC. Nasdaq
Equities
US68235M1053
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 06/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 14/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 18/01/23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 31/10/18 |
Alicia Tozier
SAM | Sales & Marketing | - | 01/03/22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 07/02/22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 31/10/18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 25/04/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 12/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 10/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 06/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 14/09/15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 30/10/17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 19/04/20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 19/04/20 |
Julia Haller
BRD | Director/Board Member | 69 | 10/08/22 |
Director/Board Member | 39 | 10/09/17 | |
Andong Huang
BRD | Director/Board Member | 27 | 18/06/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,298,542 | 13,636,212 ( 61.15 %) | 0 | 61.15 % |
Company contact information
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.73% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |